Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Alzamend Neuro, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +2 vs. Q3 2025
- Shares held
- 245.6K
- +98.0K (+66.4%) vs. Q3 2025
- Total value
- $447.2K
- +$95.8K (+27.3%) vs. Q3 2025
- New holders
- 3
- 5 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $3.26M |
| Q1 2026 | 13 | $723.1K |
| Q4 2025 | 13 | $447.2K |
| Q3 2025 | 11 | $351.3K |
| Q2 2025 | 7 | $6.36K |
| Q1 2025 | 11 | $59.9K |
| Q4 2024 | 17 | $131.7K |
| Q3 2024 | 12 | $71.2K |
| Q2 2024 | 16 | $150.5K |
| Q1 2024 | 13 | $386.8K |
| Q4 2023 | 16 | $334.7K |
| Q3 2023 | 27 | $1.49M |
| Q2 2023 | 24 | $3.13M |
| Q1 2023 | 26 | $2.64M |
| Q4 2022 | 33 | $3.98M |
| Q3 2022 | 17 | $9.41M |
| Q2 2022 | 21 | $2.70M |
| Q1 2022 | 22 | $4.01M |
| Q4 2021 | 20 | $1.66M |
| Q3 2021 | 17 | $1.99M |
| Q2 2021 | 11 | $2.58M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Alzamend Neuro, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DRW Securities, LLC | 116,319 | $211.7K | 0.02% | +25,074+27.5% | Added |
| Geode Capital Management, LLC | 27,506 | $50.1K | 0.00% | +6,928+33.7% | Added |
| UBS Group AG | 24,567 | $44.7K | 0.00% | +22,492+1,084.0% | Added |
| Vanguard Group Inc | 21,620 | $39.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 18,000 | $32.8K | 0.00% | +18,000 | New |
| Virtu Financial LLC | 12,582 | $23.0K | 0.00% | +12,582 | New |
| XTX Topco Ltd | 12,470 | $22.7K | 0.00% | +12,470 | New |
| Clearstead Advisors, LLC | 10,000 | $18.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,081 | $3.79K | 0.00% | +475+29.6% | Added |
| BlackRock, Inc. | 437 | $795 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 43 | $78 | 0.00% | +6+16.2% | Added |
| SBI Securities Co., Ltd. | 22 | $40 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |